A 35 year old woman presented with severe primary hypothyroidism and galactorrhea. A very high prolactin level was also detected and computerized tomography scan of the sellar region demonstrated an enlarged pituitary gland associated with contrast enhancement. Replacement therapy with thyroxine corrected both biochemical and clinical abnormalities but empty sella developed during this therapy. It is concluded that empty sella may be related to thyroxine-induced shrinkage of lactotroph and/or thyrotroph cell hyperplasia.
Introduction
Empty sella is characterized by an intrasellar herniation ofthe suprasellar subarachnoid space. It may be primary or secondary in origin. Secondary empty sella is usually related to surgical treatment or X-ray therapy and it has also been reported after spontaneous infarction of pituitary tumours, Sheehan's syndrome and bromocriptine therapy in patients with prolactinoma and functionless pituitary tumour. '15 We present a patient with primary hypothyroidism and hyperprolactinaemia in whom empty sella developed during thyroxine replacement therapy. owever, only one of their patients had marked hyperprolactinaemia which was much less than in our case. Since both TSH and PRL levels are high in some patients with primary hypothyroidism characterized by enlarged pituitary gland, we think that it is not possible to say whether pituitary enlargement or tumour is due to lactotroph and/or thyrotroph cell abnormality in this condition.
Whatever the pituitary abnormality, pituitary enlargement due to primary hypothyroidism may cause suprasellar extension and visual field defects which are reversible with thyroxine therapy.6"15-'7
The incidence of significant hyperprolactinaemia due to primary hypothyroidism varies between 0 and 25%."o18 Although the incidence of pituitary enlargement in primary hypothyroidism associated with hyperprolactinaemia is not known, we think that severe hypothyroidism may rarely be associated with hyperprolactinaemia and an enlarged pituitary gland. The mechanism of hyperprolactinaemia in primary hypothyroidism is not understood. We previously postulated that there may be a close relation between prolactin secretion and peripheral thyroid hormone levels in relation to observations in a patient with Sheehan's syndrome presenting with hyperprolactinaemia. '9 CT scan of the pituitary gland taken when the patient's PRL and TSH levels were normal revealed a large empty sella. Thyroxine replacement therapy brought TSH level within the normal range and prolactin came down simultaneously. In other words, lactotrophs and/or thyrotrophs shrunk significantly in a short time as a result of the removed overstimulation on the pituitary gland. Empty sella has not been reported in the case reports mentioned above. Jawada et al. reported a patient with primary hypothyroidism characterized by high PRL and TSH levels and an enlarged pituitary gland.20 In this patient, thyroid replacement therapy resulted in regression of the enlarged pituitary and also a partially empty sella demonstrated by pneumonencephalogram. 20 In another patient with primary hypothyroidism whose PRL and TSH levels were above normal intrasellar cisternal herniation demonstrated by CT scan developed after thyroxine therapy. 2' Since only a few patients with primary hypothyroidism and hyperprolactinaemia develop an empty sella after thyroxine therapy, it can be speculated that this occurs only in patients having an abnormal diaphragma sella. We conclude that thyroxine replacement therapy will result in normalization of the high PRL and TSH levels and shrinkage of the pituitary gland and very rarely an empty sella may develop. 
